Search company, investor...
Apollo Endosurgery company logo

Apollo Endosurgery

apolloendo.com

Founded Year

2006

Stage

Reverse Merger | IPO

Total Raised

$184.07M

About Apollo Endosurgery

Apollo Endosurgery (NASDAQ: APEN) is a medical device company focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The company's device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs.

Headquarters Location

1120 S. Capital of Texas Highway Building 1, Suite 300

Austin, Texas, 78746,

United States

512-279-5100

Missing: Apollo Endosurgery's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Apollo Endosurgery's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Apollo Endosurgery

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Apollo Endosurgery is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

11,936 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health IT

7,901 items

Apollo Endosurgery Patents

Apollo Endosurgery has filed 1 patent.

The 3 most popular patent topics include:

  • Endoscopy
  • Digestive system surgery
  • Medical equipment
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/24/2017

10/12/2021

Endoscopy, Medical equipment, Digestive system surgery, Digestive system, Surgery

Grant

Application Date

3/24/2017

Grant Date

10/12/2021

Title

Related Topics

Endoscopy, Medical equipment, Digestive system surgery, Digestive system, Surgery

Status

Grant

Latest Apollo Endosurgery News

Endoscopic Closure Systems Market to reach over USD 1.22 billion by the year 2030 - InsightAce Analytic

Nov 21, 2022

News Provided By Share This Article Global Endoscopic Closure Systems Market seg Global endoscopic closure systems market is estimated to reach over USD 1.22 billion by 2030, exhibiting a CAGR of 7.51% during the forecast period. Key Players in the Endoscopic Closure Systems Market: Coopersurgical, Steris, Apollo Endosurgery, Boston Scientific Corporation, Ovesco Endoscopy Ag, Abbott,Medtronic,Olympus Corporation” — Insightace Analytic NEW JERSEY, NJ, USA, November 21, 2022 / EINPresswire.com / -- InsightAce Analytics Pvt. Ltd. announces the release of a market assessment report on the " Global Endoscopic Closure Systems Market (By Product (Endoscopic Clips/End Clips (Over-The-Scope Clips), Overstitch Endoscopic Suturing Systems, Endoscopic Vacuum-Assisted Closure Systems And Other Products), Distributional Channel ( Direct And Indirect ) And End-Use (Hospitals, Clinics And Ambulatory Surgery Centers))- Market Outlook and Industry Analysis 2030" The global endoscopic closure systems market is estimated to reach over USD 1.22 billion by 2030, exhibiting a CAGR of 7.51% during the forecast period. Request for Sample: https://www.insightaceanalytic.com/request-sample/1446 An endoscopic suturing device that permits the installation of running or interrupted full-thickness sutures was developed. This gadget was based on the Eagle Claw device, but it was more sophisticated and could only be used with one endoscope. Because of their advantages over previously available equipment, endoscopic suturing systems are projected to transform the endoscopic closure systems market. The major key factors driving the growth of the global endoscopic closure systems market are the increasing need for and interest in developing dedicated devices and techniques that enable the endoscopic closure of small GI perforations, as well as the increasing adoption of minimally invasive endoscopic procedures. The increased global prevalence of gastrointestinal and stomach cancer is likely to impact the market substantially. The market is expected to develop significantly as the older population grows. Endoscopic surgery is gaining popularity because it uses advanced technology to reach interior organs through small incisions, resulting in less discomfort and faster recovery than traditional surgical approaches. These reasons are anticipated to stimulate demand for endoscopic closure systems. The market's progress is limited by a scarcity of competent personnel experienced in performing endoscopic operations. Prominent Players in the Endoscopic Closure Systems Market: Coopersurgical, Inc. (The Cooper Companies Inc.) Steris Drivers- Market drivers, such as the increased demand for endoscopic closure devices to treat gastrointestinal perforations, are being heavily used by market players to attain growth potential. Endoscopic closure devices market growth will be driven by the increasing need for endoscopic closure devices to treat gastrointestinal perforations. Advances in endoscopic closure device technology will further support market expansion. Market players are investing heavily in R&D to develop and launch devices that are precise, safe, efficient, easy to maneuver, have improved ergonomics, and have an intuitive user interface. These design improvements have resulted in more reliable results from these devices, contributing to the demand for advanced endoscopic closure devices. Challenges: The market's progress is limited by a scarcity of competent personnel experienced in performing endoscopic operations. However, factors such as the availability of substitutes will threaten market participants' growth. High expenses, the danger of infection, and tight rules and regulations established by multiple government agencies will hinder the market for endoscopic closure. Regional Trends: The North American endoscopic closure systems market is expected to register a share in the market. Investments in technologically advanced research and treatment platforms, rising cancer and GI tract problem incidence, and the presence of a large number of endoscopic clip manufacturers in the region are expected to be significant growth factors in the endoscopic closure system market. The growing usage of improved diagnostic tools in gastrointestinal (GI) disorders such as inflammation, surgical anastomoses, and neoplastic fistulae, as well as the existence of essential market competitors, are driving growth in the United States. Besides, Asia Pacific had a substantial share in the endoscopic closure systems market. The region's market is expanding due to an increase in arterial bleeding among cardiac patients and GI-related surgeries, which have the most significant market share due to the large patient population. Enquiry Before Buying: https://www.insightaceanalytic.com/enquiry-before-buying/1446 Recent Developments: • In July 2022, Apollo Endosurgery, Inc., a global leader in minimally invasive medical devices for gastrointestinal and bariatric surgeries, announced the electronic publication of the landmark Multi-center ESG Randomized Interventional Trial (MERIT) Study in The Lancet. • In February, 2022-CooperCompanies stated that it signed a binding letter of intent to acquire Cook Medical's Reproductive Health business, a minimally invasive medical equipment manufacturer. Segmentation of Endoscopic Closure Systems Market- By Product-

Apollo Endosurgery Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Apollo Endosurgery Rank

Apollo Endosurgery Frequently Asked Questions (FAQ)

  • When was Apollo Endosurgery founded?

    Apollo Endosurgery was founded in 2006.

  • Where is Apollo Endosurgery's headquarters?

    Apollo Endosurgery's headquarters is located at 1120 S. Capital of Texas Highway, Austin.

  • What is Apollo Endosurgery's latest funding round?

    Apollo Endosurgery's latest funding round is Reverse Merger.

  • How much did Apollo Endosurgery raise?

    Apollo Endosurgery raised a total of $184.07M.

  • Who are the investors of Apollo Endosurgery?

    Investors of Apollo Endosurgery include Lpath, Athyrium Capital Management, PTV Sciences, H.I.G. BioHealth Partners, Remeditex Ventures and 7 more.

  • Who are Apollo Endosurgery's competitors?

    Competitors of Apollo Endosurgery include Millstone Medical Outsourcing, The Foundry Visionmongers, CardiAQ Valve Technologies, MAKO Surgical, MedVenture Technology and 12 more.

Compare Apollo Endosurgery to Competitors

J
J-pac

J-PAC is a supplier of medical contract manufacturing, assembly, and packaging services. Participating as a member of the Medipharm Manufacturing Group, J-PAC offers a "Continuum of Service" that starts with the package design, product prototyping and clinical trials leading to full scale medical device production.n

Viant Logo
Viant

Viant provides technical molding services for the medical device industry, offering a range of engineering and manufacturing capabilities that support original equipment manufacturers with producing diagnostic, orthopedic, surgical, and other medical products.

C
Cascade Life Solutions

Cascade Life Solutions is an FDA registered, ISO certified company engaged in medical device contract manufacturing and assembly. Cascade Life's focus is to provide "single source" for medical device contract manufacturing (class I, II and III) services.

R
Rose Technologies

Rose Technologies is engaged in medical device design, manufacturing, and assembly automation needs.

DTx Logo
DTx

Designs, manufactures, and aims to provide contract manufacturing and logistics services for embedded systems for medical device, broadcast equipment, and point-of-sale system customers.

G
Graphic Surgery

Graphic Surgery is a physician founded medical service company founded in 2000, which aims to ensure that consumers have the right surgery at the right time with the right outcome. They work with surgeons, employers and insurers to educate consumers about the most common surgeries and to promote transparency. This information aims to provide consumers the knowledge and confidence to select the right providers, discuss all treatment options and have better outcomes when they do have surgery. There are currently 3 main products. Surgery Insight, Surgery Analytics and Surgery By Design.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.